Cargando…
Transitioning of Helicobacter pylori Therapy from Trial and Error to Antimicrobial Stewardship
Helicobacter pylori is the only major infection for which antimicrobial therapy is not designed using the principles of antimicrobial stewardship. Traditionally, antimicrobial therapy is a susceptibility-based therapy, achieves high cure rates, and includes surveillance programs to regularly provide...
Autor principal: | Graham, David Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601139/ https://www.ncbi.nlm.nih.gov/pubmed/33023041 http://dx.doi.org/10.3390/antibiotics9100671 |
Ejemplares similares
-
Helicobacter pylori diagnosis and therapy in the era of antimicrobial stewardship
por: Shiotani, Akiko, et al.
Publicado: (2021) -
Antibiotic Resistance, Susceptibility Testing and Stewardship in Helicobacter pylori Infection
por: Ng, Ho-Yu, et al.
Publicado: (2023) -
Errors in Crystal structure of HINT from Helicobacter pylori
por: Maize, Kimberly M.
Publicado: (2016) -
Helicobacter pylori urease for diagnosis of Helicobacter pylori infection: A mini review
por: Graham, David Y., et al.
Publicado: (2018) -
Rates of Antimicrobial Resistance in Helicobacter pylori Isolates From Clinical Trial Patients Across the US and Europe
por: Mégraud, Francis, et al.
Publicado: (2023)